The effect and mechanism of Panax notoginseng saponins through inhibiting JNK/c-Jun signaling pathway in calcific aortic valve disease
Experimental Studies|更新时间:2024-12-02
|
The effect and mechanism of Panax notoginseng saponins through inhibiting JNK/c-Jun signaling pathway in calcific aortic valve disease
Journal of Beijing University of Traditional Chinese MedicineVol. 47, Issue 11, Pages: 1550-1561(2024)
作者机构:
1.中国中医科学院西苑医院国家中医心血管病临床医学研究中心 北京 100091
2.中国中医科学院广安门医院博士后流动站
3.福建中医药大学中西医结合学院
4.中国医学科学院阜外医院冠心病中心
作者简介:
YU Zikai, Ph.D., Associate Researcher, Attending Physician. National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No.1, Xiyuan Caochang Road, Haidian district, Beijing 100091. E-mail: ztyuzikai@163.com
基金信息:
National Natural Science Foundation of China(82104679)
LI Hongzheng, LIU Tianjiao, SHANG Zucheng, et al. The effect and mechanism of Panax notoginseng saponins through inhibiting JNK/c-Jun signaling pathway in calcific aortic valve disease[J]. Journal of beijing university of traditional chinese medicine, 2024, 47(11): 1550-1561.
DOI:
LI Hongzheng, LIU Tianjiao, SHANG Zucheng, et al. The effect and mechanism of Panax notoginseng saponins through inhibiting JNK/c-Jun signaling pathway in calcific aortic valve disease[J]. Journal of beijing university of traditional chinese medicine, 2024, 47(11): 1550-1561. DOI: 10.3969/j.issn.1006-2157.2024.11.010.
The effect and mechanism of Panax notoginseng saponins through inhibiting JNK/c-Jun signaling pathway in calcific aortic valve disease
saponins (PNS) in inhibiting c-Jun N-terminal protein kinase (JNK)/c-Jun signaling pathway activation to alleviate calcific aortic valve disease (CAVD) in mice.
Methods
2
Twenty-one male ApoE
-/-
mice aged 6 to 8 weeks were randomly divided into the model
PNS high-dose (60 mg/kg)
and PNS low-dose (30 mg/kg) groups using the random number table method
with seven mice per group. Nine male C57BL/6 mice aged 6 to 8 weeks were used as the control group. Mice in the control group were fed a normal diet
whereas ApoE
-/-
mice were fed a high-fat diet for 12 weeks. After 12 weeks
three C57BL/6 and
three ApoE
-/-
mice (one ApoE
-/-
mice from each group) were randomly selected to evaluate the CAVD modeling effect. After confirming successful modeling
the PNS high- and low-dose groups received daily intragastric PNS administration. The control and model groups were administered an equal volume of stroke-physiological saline solution by gavage for 4 consecutive weeks. The valve annulus diameter and peak velocity of the mice in each group were then detected using ultrasound. The degree of aortic valve calcification was evaluated using von Kossa and Alizarin Red S staining. The serum triglycerides (TG)
total cholesterol (TC)
low-density lipoprotein cholesterol (LDL-C)
and high-density lipoprotein cholesterol (HDL-C) were detected by biochemical method. Inflammatory factor interleukin-4 (IL-4)
tumor necrosis factor-α (TNF-α)
interleukin-1β (IL-1β)
and interleukin-10 (IL-10) levels were determined using an enzyme-linked immunosorbent assay. The expressions of calcification markers
runt-related transcription factor 2 (RUNX2)
and bone morphogenetic protein 2 (BMP2) were detected using immunohistochemistry. Aortic valve cell apoptosis was evaluated using TUNEL staining
and JNK/c-Jun signaling pathway-related mRNA and mean fluorescence intensity were detected using quantitative real-time PCR and immunofluorescence
respectively.
Results
2
Compared with the control group
the mice in the model group showed an increase in serum TC
TG
LDL-C
TNF-α
and IL-1β levels
a decrease in IL-4 and IL-10 levels
a decrease in annulus diameter
an increase in peak flow velocity
and an increase in von Kossa and Alizarin Red S staining-positive areas. Additionally
the model group showed an increase in aortic valve cell apoptosis rate
an increase in BMP2 and RUNX2-positive rates
and an increase in JNK and c-Jun mRNA expression levels and p-JNK/JNK and p-c-Jun/c-Jun (
P
<
0.05). Compared to the model group
the PNS low-dose group showed a decrease in seru
m TC
LDL-C
and TNF-α levels
an increase in annulus diameter
a decrease in peak flow velocity
and a decrease in positive area in Alizarin Red S staining. Furthermore
the PNS low-dose group showed a decrease in BMP2 and RUNX2-positive rates
JNK and c-Jun mRNA expression levels
and p-JNK/JNK and p-c-Jun/c-Jun (
P
<
0.05). The PNS high-dose group showed an increase in HDL-C
IL-4 and IL-10 levels
a decrease in serum TC
LDL-C
TNF-α
and IL-1β levels
an increase in annulus diameter
a decrease in peak flow velocity
and a decrease in von Kossa and Alizarin Red S staining-positive areas and cell apoptosis rate. The PNS high-dose group also showed a decrease in BMP2 and RUNX2 positive staining rates
JNK and c-Jun mRNA expression levels
and p-JNK/JNK and p-c-Jun/c-Jun (
P
<
0.05).
Conclusion
2
PNS may reduce valvular cell apoptosis
alleviate inflammation
and protect against aortic valve calcification in mice by inhibiting the activation of JNK/c-Jun signaling pathway.
关键词
Keywords
references
SMALL AM , YUTZEY KE , BINSTADT BA , et al . Unraveling the mechanisms of valvular heart disease to identify medical therapy targets: a scientific statement from the American heart association [J ] . Circulation , 2024 , 150 ( 6 ): e109 - e128 .
MOURA LM , RAMOS SF , ZAMORANO JL , et al . Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis [J ] . J Am Coll Cardiol , 2007 , 49 ( 5 ): 554 - 561 .
Cowell SJ , Newby DE , Prescott RJ , et al . A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis [J ] . N Engl J Med , 2005 , 352 ( 23 ): 2389 - 2397 .
GARG V . The role of lipoprotein(a) in calcific aortic valve disease: insights from a large-cohort genetic study [J ] . JAMA Cardiol , 2018 , 3 ( 1 ): 24 - 25 .
ZHU ZJ , LIU ZR , ZHANG DH , et al . Models for calcific aortic valve disease in vivo and in vitro [J ] . Cell Regen , 2024 , 13 ( 1 ): 6 .
ZHOU YZ , YUAN ZS , WANG M , et al . Liraglutide attenuates aortic valve calcification in a high-cholesterol-diet-induced experimental calcific aortic valve disease model in apolipoprotein E-deficient mice [J ] . J Cardiovasc Dev Dis , 2023 , 10 ( 9 ): 386 .
VOGL BJ , NIEMI NR , GRIFFITHS LG , et al . Impact of calcific aortic valve disease on valve mechanics [J ] . Biomech Model Mechanobiol , 2022 , 21 ( 1 ): 55 - 77 .
YANG Y , WANG ZW , CHEN Z , et al . Current status and etiology of valvular heart disease in China: a population-based survey [J ] . BMC Cardiovasc Disord , 2021 , 21 ( 1 ): 339 .
YU JY , WANG Z , BAO QY , et al . Global burden of calcific aortic valve disease and attributable risk factors from 1990 to 2019 [J ] . Front Cardiovasc Med , 2022 , 9 : 1003233 .
MOHAMMADYARI P , VIECELI DALLA SEGA F , FORTINI F , et al . Deep-learning survival analysis for patients with calcific aortic valve disease undergoing valve replacement [J ] . Sci Rep , 2024 , 14 ( 1 ): 10902 .
MONCLA LM , BRIEND M , BOSSÉ Y , et al . Calcific aortic valve disease: mechanisms, prevention and treatment [J ] . Nat Rev Cardiol , 2023 , 20 ( 8 ): 546 - 559 .
YANG XC , XIONG XJ , WANG J . Sanqi Panax notoginseng injection for angina pectoris [J ] . Evid Based Complement Alternat Med , 2014 , 2014 : 963208 .
DUAN L , XIONG XJ , HU JY , et al . Panax notoginseng saponins for treating coronary artery disease: a functional and mechanistic overview [J ] . Front Pharmacol , 2017 , 8 : 702 .
XU Y , TAN HY , LI S , et al . Panax notoginseng for inflammation-related chronic diseases: a review on the modulations of multiple pathways [J ] . Am J Chin Med , 2018 , 46 ( 5 ): 971 - 996 .
YANG H , LIU ZD , HU XK , et al . Protective effect of Panax notoginseng saponins on apolipoprotein-E-deficient atherosclerosis-prone mice [J ] . Curr Pharm Des , 2022 , 28 ( 8 ): 671 - 677 .
LI GZ , SHEN N , DENG HF , et al . Abnormal mechanical stress on bicuspid aortic valve induces valvular calcification and inhibits Notch1/NICD/Runx2 signal [J ] . PeerJ , 2023 , 11 : e14950 .
KHAN K , YU B , KIWAN C , et al . The role of Wnt/β-catenin pathway mediators in aortic valve stenosis [J ] . Front Cell Dev Biol , 2020 , 8 : 862 .
WANG B , LI F , ZHANG C , et al . High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells [J ] . J Thorac Cardiovasc Surg , 2016 , 151 ( 1 ): 255 - 262 .
CUI J , ZHANG M , ZHANG YQ , et al . JNK pathway: diseases and therapeutic potential [J ] . Acta Pharmacol Sin , 2007 , 28 ( 5 ): 601 - 608 .
Effects of Huashi Runzao Prescription on apoptosis and function of the submandibular gland in Sjögren′s syndrome model mice by regulating Hippo-YAP/TAZ expression
Study on antidepressant effect and mechanism of Sangju Jieyu Formula on behavioral despair mouse model and on olfactory bulbectomized mouse model
Inhibition of transplanted tumor growth and inducing of apoptosis by Yiqi Yangyin Jiedu Fang in mice with Lewis lung cancer
Influences of Bushen Huayu Fang on stability of artherosclerosis plaque and apoptosis in plaque in ApoE-/-mice
Exploration of the protection of mild moxibustion on ovarian function in mice with premature ovarian insufficiency by regulating AMPK/PGC-1α signal, thus inhibiting the response to oxidative stress
Related Author
HUANG Ziwei
TAO Qingwen
LIAO Jiahe
YU Xinbo
HE Qian
TANG Bojie
LUO Jing
SHEN Xinming
Related Institution
Graduate School, Beijing University of Chinese Medicine
Traditional Chinese Medicine Department of Rheumatism, China-Japan Friendship Hospital, Beijing Key Laboratory of Immune Inflammatory Disease
Nanjing University of Chinese Medicine
State Key Laboratory of Toxicology and Medical Countermeasures, Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences
School of Medicine, Anhui University of Science and Technology